期刊文献+

载VEGF-ASODN PLGA纳米粒抑制大鼠肝癌新生血管生成的作用 被引量:2

Anti-angiogenesis effectiveness of VEGF antisense oligodeoxynucleotide loaded polylactic-co-glycolic acid nanoparticles in the treat ment of Walker-256 hepatoma in rats
下载PDF
导出
摘要 目的研究VEGF-ASODN PLGA纳米粒对大鼠肝癌血管生成的抑制作用。方法建立大鼠Walker-256肝癌模型。48只大鼠随机分为4组,均采用肝动脉插管方法注射药物。A组生理盐水组,B组PLGA组,C组单纯反义ODN组,D组VEGF-ASODN PLGA纳米粒组。每组3只大鼠于治疗后1周行组织学及免疫组化检查,以抗CD34单克隆抗体显示血管内皮细胞,根据CD34阳性血管内皮细胞记数来测定肿瘤微血管密度(MVD)。结果常规病理检查,A、B组组织形态学相似,C组癌细胞巢减小,部分癌细胞核固缩,出现小片坏死灶,而D组癌细胞核固缩和核碎裂现象明显增多、核染色质浓缩、细胞体积缩小,并出现多个片状和灶性坏死;MVD测定显示:D组MVD值为(18.1±6.15),明显低于其他各组,相差非常显著(P<0.01)。结论载VEGF反义寡核苷酸纳米粒能更有效抑制肿瘤血管生成,降低肿瘤微血管密度。 Objective To study the anti-angiogenesis effectiveness by using VEGF ASODN loaded PLGA nanoparticles in the treatment of Walker-256 hepatoma in rats. Methods The planted Walker-256 hepatoma model were established in 48 rats. We examined the therapeutic effectiveness by using VEGF ASODN loaded PLGA nanoparticles on planted rat models via hepatic artery infusion. Four treatment groups were compared with 12 rats in each group: ① Normal saline (group A); ② Nothing loaded PLGA (group B); ③ AS ODN (group C); ④ VEGF-ASODN loaded PLGA nanoparticles (group D). Microvessel density (MVD) was evaluated with immunostained by anti-CD34 antibody in 3 rats for each group. Results Microscopically, the morphological features in group A was similar with that of group B. Tumors in group C is often characterized by reduced tumor nests, karyopyknosis and snip necrosis in some tumor cells. Compared with group C, the karyopyknosis and the karyorrhexis of the tumor cells were obvious increased in group D. Furthermore, the chromatin condensation, the contraction, the snip and focal necrosis of tumor cells were also demonstrated. Compared with other three groups, microvessel density (MVD) was significantly reduced in group D (18. 1 ± 6. 16, P〈0.01). Conclusion Transarterial infusion of VEGF-ASODN loaded PLGA nanoparticles may significantly enhance the anti-angiogenesis effect in comparison with using ASODN alone in the treatment of Walke〉256 hepatoma in rats.
出处 《中国医学影像技术》 CSCD 北大核心 2005年第11期1659-1662,共4页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金面上项目(30471993) 上海市科技发展基金(03ZR14030)
关键词 肝肿瘤 抗血管生成 血管内皮生长因子 反义寡核苷酸 微血管密度 纳米粒 聚乳酸-聚乙醇酸共聚物 Liver neoplasms Anti-angiogenesis Vascular endothelial growth factor Antisense oligodeoxynuclieotide Microvessel density Nanoparticle Polylactic-co-glycolic acid
  • 相关文献

参考文献6

二级参考文献21

  • 1张志荣,廖工铁,叶利民.柱切换HPLC法研究米托蒽醌毫微粒冻干静脉注射剂的药代动力学[J].药学学报,1995,30(11):843-847. 被引量:4
  • 2李麟荪,临床介入治疗学,1994年,1页
  • 3Pan W S,药学学报,1991年,26卷,4期,280页
  • 4Lenearts V,Raymond P,Juhasz J,et al.New method for the preparation of cyanoacrylic nanoparticles with improved colloidal properties[].Journal of Pharmacological Sciences.1984
  • 5Lenearts V,Nagelkerke J F,Vanberkel J. JC,et al.In vivo uptake of polyisobutyl cyanoacrylate nanoparticals by rat liver kupffer, indothelial, and patenchymal[].Journal of Pharmacological Sciences.1989
  • 6Song CX,Labhasetwar V,Murphy H,et al.Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery[].Journal of Controlled Release.1997
  • 7Thurmond KB 2nd,Remsen EE,Kowalewski T,et al.Packaging of DNA by shell crosslinked nanoparticles[].Nucleic Acids Research.1999
  • 8Truong-Le VL,August JT,Leong KW.Controlled gene delivery by DNA-gelatin nanopheres[].Human Gene Therapy.1998
  • 9顾公望,周汉高.肝癌病因的新概念[J].华人消化杂志,1998,6(3):185-187. 被引量:20
  • 10郑世曦,刘丽江,邵永胜,郑清平,阮幼冰,武忠弼.原发性肝癌转移与ras p53基因及其蛋白表达的关系[J].华人消化杂志,1998,6(2):104-105. 被引量:17

共引文献121

同被引文献17

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部